Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Cardiovasc Toxicol. 2016 Apr;16(2):182–192. doi: 10.1007/s12012-015-9327-x

Figure 2.

Figure 2

Top: linear regression analyses of percent methylation at variable sites in AKR7A2 versus cardiac AKR7A2 mRNA expression. Each circle depicts the average of individual samples analyzed in triplicates. Bottom: linear regression analyses of percent methylation at variable sites in AKR7A2 versus cardiac AKR7A2 protein expression in donors with and without DS. Each circle depicts the average of individual samples analyzed in triplicates.